Determinants of outcome in patients with chronic ischemic left ventricular dysfunction undergone percutaneous

Enrico Ammirati1,2,3, Valentina Guida4, Azeem Latib4

  • 1IRCCS Ospedale San Raffaele and Vita-Salute University San Raffaele, Via Olgettina 60, 20132, Milan, Italy. ammirati.enrico@hsr.it.

Insights

Percutaneous coronary interventions (PCI) for systolic left ventricular dysfunction (SLVD) show unclear prognostic impact. Key risk factors for adverse outcomes include diabetes, heart failure symptoms, and reduced ejection fraction, while stress testing may improve prognosis.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Heart Failure Research

Background:

  • Percutaneous coronary interventions (PCI) are common for ischemic systolic left ventricular dysfunction (SLVD).
  • The prognostic impact of PCI in SLVD patients remains incompletely understood.
  • SLVD is defined by a left ventricular ejection fraction (LVEF) ≤40%.

Purpose of the Study:

  • To evaluate clinical factors associated with adverse outcomes in SLVD patients undergoing PCI.
  • To identify predictors of death and a composite of death/acute decompensated heart failure (ADHF) hospitalization.
  • To assess the impact of pre-PCI stress testing on patient prognosis.

Main Methods:

  • Retrospective analysis of 385 consecutive SLVD patients (LVEF ≤40%) who underwent PCI (1999-2009).
  • Evaluation of clinical factors, including insulin-dependent diabetes mellitus (IDDM), multivessel disease, LVEF, heart failure symptoms, and age.
  • Assessment of outcomes including all-cause mortality and hospitalization for ADHF.

Main Results:

  • Median follow-up was 28 months; 21% experienced death and 28% experienced the composite outcome.
  • Independent predictors of worse outcomes included IDDM, multivessel disease, LVEF <35%, and HF symptoms.
  • Pre-PCI stress testing was associated with reduced mortality and ADHF hospitalizations (HR=0.60).
  • PCI significantly reduced angina symptoms from 63.2% to 16.3% (p<0.0001).

Conclusions:

  • IDDM, HF symptoms, multivessel disease, and LVEF <35% are associated with worse prognosis in SLVD patients undergoing PCI.
  • These factors should inform risk stratification for optimal patient management.
  • Pre-PCI stress testing may be linked to a more favorable patient outcome.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
400
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
2.0K
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
2.6K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
637
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
426
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
1.1K